Literature DB >> 5078407

Gastric acid secretion in chronic renal failure.

P S Ventkateswaran, A Jeffers, A G Hocken.   

Abstract

Contrary to the small amount of published evidence, but in accordance with clinical impression, we have found an increased incidence of peptic ulceration in people with chronic renal failure. Hyperacidic secretion in response to a standard pentagastrin test occurs in patients established on long-term dialysis treatment. The traditional liability of azotaemic patients to peptic ulceration seems not to be decreased by adequate long-term dialysis and indeed may be worsened.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5078407      PMCID: PMC1786162          DOI: 10.1136/bmj.4.5831.22

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Use of pentagastrin in a test of gastric acid secretion.

Authors:  D Johnston; K Jepson
Journal:  Lancet       Date:  1967-09-16       Impact factor: 79.321

2.  Gastrointestinal complications after renal transplantation.

Authors:  E J Hadjiyannakis; W A Smellie; D B Evans; R Y Calne
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

3.  Gastric assessment of prospective renal-transplant patients.

Authors:  E M Gordon; A G Johnson; G Williams
Journal:  Lancet       Date:  1972-01-29       Impact factor: 79.321

4.  The period and nature of hazard in clinical renal transplantation. I. The hazard to patient survival.

Authors:  T C Moore; D M Hume
Journal:  Ann Surg       Date:  1969-07       Impact factor: 12.969

5.  The upper gastrointestinal tract in patients ungergoing chronic dialysis.

Authors:  S N Wiener; V Vertes; H Shapiro
Journal:  Radiology       Date:  1969-01       Impact factor: 11.105

6.  Gastric secretory studies in patients undergoing chronic hemodialysis.

Authors:  E Schupak; J Ferayorni
Journal:  Am J Dig Dis       Date:  1968-08

7.  Compensatory changes in renal electrolyte excretion to removal of gastric HC1 in normal and uremic man.

Authors:  F Kiil; E Enger
Journal:  Scand J Clin Lab Invest       Date:  1968-12       Impact factor: 1.713

8.  Role of calcium in gastric hypersecretion, parathyroid adenoma and peptic ulcer.

Authors:  R F Barreras; R M Donaldson
Journal:  N Engl J Med       Date:  1967-05-18       Impact factor: 91.245

9.  Gastric acid secretion in patients undergoing chronic dialysis.

Authors:  H Goldstein; D Murphy; A Sokol; M E Rubini
Journal:  Arch Intern Med       Date:  1967-12

10.  Hypergastrinaemia in chronic renal failure.

Authors:  M G Korman; M C Laver; J Hansky
Journal:  Br Med J       Date:  1972-01-22
View more
  22 in total

1.  Pharmacokinetics and dynamics of famotidine in patients with renal failure.

Authors:  U Gladziwa; U Klotz; D R Krishna; H Schmitt; W M Glöckner; H Mann
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

2.  Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.

Authors:  N Inotsume; M Nishimura; S Fujiyama; K Sagara; T Sato; Y Imai; H Matsui; M Nakano
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction.

Authors:  B Krakamp; P Tanswell; H Vogel; G Bozler
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Characteristics of nonvariceal upper gastrointestinal hemorrhage in patients with chronic kidney disease.

Authors:  Chang Seok Bang; Yong Seop Lee; Yun Hyeong Lee; Hotaik Sung; Hong Jun Park; Hyun Soo Kim; Jin Bong Kim; Gwang Ho Baik; Yeon Soo Kim; Jai Hoon Yoon; Dong Joon Kim; Ki Tae Suk
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

5.  Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.

Authors:  T Takabatake; H Ohta; M Maekawa; Y Yamamoto; Y Ishida; H Hara; S Nakamura; Y Ushiogi; M Kawabata; N Hashimoto
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure.

Authors:  C W Howden; C D Payton; P A Meredith; D M Hughes; A I Macdougall; J L Reid; J A Forrest
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Gastric acid secretion in uraemia and circulating levels of gastrin, somatostatin, and pancreatic polypeptide.

Authors:  R Hällgren; J Landelius; K E Fjellström; G Lundqvist
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

8.  Gastric function and histology in chronic renal failure.

Authors:  C J Mitchell; D P Jewell; M R Lewin; J E McLaughlin; J F Moorhead
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

9.  Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.

Authors:  D A Sica; T Comstock; A Harford; F Eshelman
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  Pharmacokinetics and pharmacodynamics of H2-receptor antagonists in patients with renal insufficiency.

Authors:  U Gladziwa; U Klotz
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.